HCM II Acquisition Corp. is a special purpose acquisition company (SPAC) specializing in securing mergers and acquisitions within the healthcare sector, characterized by rapid growth and innovation. The firm is led by a team of experienced professionals who utilize strategic partnerships to uncover and capitalize on value-creation opportunities in high-potential healthcare enterprises. By focusing on emerging trends and groundbreaking solutions, HCM II aims to provide institutional investors a unique platform to invest in the transformative shifts occurring within the healthcare landscape, ultimately enhancing their portfolio exposure to this vital industry.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.48 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $25.00M |
| Float | $21.05M |
| % Insiders | 0.00% |
| % Institutions | 0.17% |
Volatility is currently contracting